ETF · VanEck
CURG VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD
ISIN IE000B9PQW54London Stock Exchange: CURGVanEck ETP AG
- Healthcare
- ETF
- ISA
- SIPP
- Accumulating
Latest close
LSE£21.63
on
- Ongoing charge
- 0.35% a year
- Fund size
- £13.3m
Source: TradingView, as of , at least 15 min delayed
At a glance
As of 30/09/2026, CURG (VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD, ISIN IE000B9PQW54) closed at £21.63 on the London Stock Exchange. Its ongoing charge is 0.35% a year (about £35 on £10,000). Over the three years to 30/09/2026 its total return was +42.7%, or +28.8% after UK CPIH inflation.
Past returns
- 1 year to 30/09/2026
- +36.5%
- +32.2% after inflation (UK CPIH)
- 3 years to 30/09/2026
- +42.7%
- +28.8% after inflation (UK CPIH)
Volatility and the largest fall need a longer record of this fund’s prices than we hold so far. They appear on this page once we do.
Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published.
How we work it out:ReturnsReturns after inflationTotal returnReal returnCPIH
Charges compared with similar funds
- Ongoing charge
- 0.35%
- a year
- On £10,000
- £35
- a year, roughly
- Over five years
- £174
- of £10,000, before growth
- 13 charge less
- 0 the same
- 4 charge more
Ongoing charge of VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD 0.35% a year, as of 01/10/2026: 4 of the 17 other healthcare funds charge more, 0 the same and 13 less (share classes counted once).
Source: Fund ongoing charges via TradingView, as of
A lower charge is not a promise of a higher return: what the fund holds matters more. Charges are the fund’s own published ongoing charges figure.
Read more:Ongoing charge (OCF)OCF and TERFee dragHow charges add up
In plain English
VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD is an exchange-traded fund (ETF) from VanEck, launched in 2022.
It tracks the MVIS Global Future Healthcare ESG Index - Benchmark TR Net.
You buy and sell it through a share-dealing account or platform during stock-market hours, like a share.
Its ongoing charge is 0.35% a year — about £35 a year on every £10,000 invested, taken from the fund's value rather than billed to you.
Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
Healthcare: Pharmaceutical, biotech and medical-equipment companies.
Terms:ETFIndex fundUCITSAccumulating or incomeShare classISIN
Key facts
- Ticker
- CURG
- ISIN
- IE000B9PQW54
- Provider
- VanEck
- Tracks
- MVIS Global Future Healthcare ESG Index
- Structure
- ETF
- An exchange-traded fund: bought and sold on the stock exchange through the day, like a share.
- Income
- Accumulating
- Income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
- Ongoing charge
- 0.35% a year · about £35 on £10,000
- Fund size
- £13.3m
- Launched
- Domicile
- Ireland
- Can be held in
- ISA and SIPP
- Currency hedged
- No
- Price currency
- Pounds (GBP)
- Category
- Healthcare
Price chart
Since 14/08/2026, the closing price went from £17.80 on 14/08/2026 to £21.63 on 30/09/2026 (+21.6%). The lowest close shown was £17.80 on 14/08/2026 and the highest £21.63 on 30/09/2026.
Chart: closing prices we have recorded since 14/08/2026.
Source: TradingView, as of , at least 15 min delayed
Five years of prices, and after inflation
2 weekly closes, from 14/08/2026 to 30/09/2026. The same history in September 2026 pounds, adjusted with ONS CPIH inflation.
Create a free account to see the 5-year price chart and the after-inflation chart
Sign-up takes an email address. There is no card to enter and nothing to pay.
How we work it out:Prices and returnsNAV and price
What it holds
Top 10 holdings
| Rank# | Holding | Weight as a percentage of the fund |
|---|---|---|
| 1 | ModernaMRNA | 9.12% |
| 2 | Vertex Pharmaceuticals | 7.36% |
| 3 | NateraNTRA | 6.89% |
| 4 | Regeneron PharmaceuticalsREGN | 6.89% |
| 5 | Veeva SystemsVEEV | 6.53% |
| 6 | IlluminaILMN | 6.13% |
| 7 | DexComDXCM | 5.19% |
| 8 | Guardant HealthGH | 4.52% |
| 9 | Alnylam PharmaceuticalsALNY | 3.95% |
| 10 | BioNTechBNTX | 3.70% |
Source: VanEck, holdings as published, as of , company pages by TradingView
Where it invests
The portfolio by sector, country and type of asset, as a share of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed.
By sector
- Health Care97.4%
- Consumer Staples2.6%
By country
- United States85.4%
- China4.5%
- Germany3.7%
- Australia1.8%
- Switzerland1.3%
- Japan1.2%
- Sweden1.1%
- United Kingdom0.6%
- Other countries0.5%
49 holdings are listed for this fund. All 49 holdings of CURG, with the full split by sector, country and type of asset.
More of the portfolio
The fund publishes 49 holdings; the ten largest make up 60.3% of it. The fund's portfolio is also split by currency.
Create a free account to see the full holdings list and the currency, maturity and credit-quality breakdowns
Sign-up takes an email address. There is no card to enter and nothing to pay.
Holdings:Compare what it holds with another fundHoldings overlapHow overlap is measured
Funds tracking the same index
2 funds track MVIS Global Future Healthcare ESG Index - Benchmark TR Net, this one included and share classes counted once; their ongoing charges range from 0.35% to 0.45% a year (30/09/2026).
| Fund | 1 year |
|---|---|
| VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USDThis fundAccumulating · 0.35% a year | +36.5% |
| VanEck Sustainable Future of Food UCITS ETF Accum A USDAccumulating · 0.45% a year | −3.4% |
Source: TradingView reported returns and fund ongoing charges, as of
Read more:Index fundsTracking differenceHow funds are compared
Other versions of this fund
Questions people ask
What is the ongoing charge of CURG?
The ongoing charge of CURG is 0.35% a year — about £35 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD 0.35% a year, as of 01/10/2026: 4 of the 17 other healthcare funds charge more, 0 the same and 13 less (share classes counted once).
What does CURG track?
CURG tracks the MVIS Global Future Healthcare ESG Index - Benchmark TR Net.
Is CURG accumulating or distributing?
CURG is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you.
What is the ISIN of CURG?
The ISIN of CURG is IE000B9PQW54. An ISIN identifies one exact share class of a fund; CURG is its ticker on the London Stock Exchange.
How has CURG done after inflation?
Over the three years to 30/09/2026 CURG’s total return was +42.7%, or +28.8% after UK CPIH inflation. Past performance is not a guide to future returns.
Similar funds
- XWHSXtrackers MSCI World Health Care UCITS ETF0.25% a year · £2.3bn
- IHCUiShares S&P 500 Health Care Sector UCITS ETF0.15% a year · £1.8bn
- 0DW6Amundi MSCI World Health Care UCITS ETF EUR ACC0.30% a year · £555m
- ESIHiShares MSCIEurope Health Care Sector UCITS ETF AccumEUR0.18% a year · £555m
- XSHCXtrackers MSCI USA Health Care UCITS ETF0.12% a year · £548m
- CH5Amundi STOXX Europe 600 Healthcare UCITS ETF -Acc- Capitalisation0.30% a year · £547m
- AGESiShares Ageing Population UCITS ETF0.40% a year · £509m
- 0MP1iShares STOXX Europe 600 Health Care UCITS ETF (DE)0.46% a year · £453m
Sources and dates
- Prices
- London Stock Exchange closes via TradingView, at least 15 minutes delayed, latest
- Returns
- TradingView reported returns (net asset value with income reinvested where available)
- Inflation
- ONS CPIH, latest month published
- Charges
- The fund’s ongoing charges figure, via TradingView
- Holdings
- VanEck, as published,
- Identity
- FCA Financial Instruments Reference Data System (FIRDS) and the issuer
- Fund size
- TradingView, converted to pounds at the latest ECB reference rate
Methodology:Data sourcesReturnsCategoriesAll methods
A machine-readable copy of this page: Markdown.